TransMedics Group, Inc. (TMDX) stock analysis
TMDX · TransMedics Group, Inc.
Latest recorded price: USD 92.21
Sector and industry: Healthcare · Medical Devices
A reliable intrinsic value could not be calculated for TMDX; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 86.4%, free cash flow margin 22.1%, ROIC 18.2%. The model flags 1 risk signal for this company.